Agomab Therapeutics
Series AAgomab Therapeutics raised €21M in a Series A round in Apr 2019. The company is based in Ghent, Belgium. Investors in the round: Advent France Biotechnology, V-Bio Ventures. Data as of Nov 2026.
Amount raised
€21M
€21,000,000
Native amount
21,000,000 EUR
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €21M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Apr 2019
Round type
series a
Amount (EUR)
€21M